News | Wearables | May 10, 2021

Vendors and ACC Collaborate With Consumer Technology Association to Help Clinicians and Patients Understand Cardiovascular Devices

Philips, Samsung, Abbott and Omron join the initiative to develop evaluation criteria that companies can use to better educate clinicians as they recommend devices to their patients

The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. #wearables

The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. 


May 10, 2021 – Today, the Consumer Technology Association (CTA) announced it is collaborating with the American College of Cardiology (ACC) on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. The working group, which includes members from ACC, Philips, Samsung, Abbott, Omron, and others will develop evaluation criteria that companies can use to better educate clinicians as they recommend devices to their patients.

Clinicians find value in using technology to better monitor and manage a patient’s health. But given the large variety of devices available on the market today, clinicians are not always certain which type is best suited to track a specific disease. Through this project, experts from the tech sector and health care setting will build guidance for device manufacturers in how to communicate the capability of individual products to clinicians and support that appropriate devices are being recommended for use by patients.

“The digital transformation of health care delivery is a priority for the ACC, and we are committed to leading the way in finding and implementing innovative ways to transform cardiovascular care and improve heart health,” said John Rumsfeld, M.D., Ph.D., FACC, chief innovation officer and chief science officer, ACC. “Through this collaborative effort we’re spanning health care and tech to give both clinicians and patients confidence when using health care devices to monitor and treat cardiovascular disease.”

“Health tech devices are an extension of clinicians’ practice, so when you’re unable to see a doctor or experience symptoms the device can step in and report the information to your provider,” said Rene Quashie, VP, digital health, CTA. “Frameworks like ours will help clinicians make an informed recommendation to their patients with the goal of providing holistic care and, ultimately, better outcomes for patients.”

A multidisciplinary group of leaders in AI and digital health recognized gaps in knowledge around implementing health care devices into patient care and determined the need for best practices during discussions at ACC’s Applied Health Innovation Consortium 2020 summit on virtual care, of which CTA is a member.

So far, the biggest challenge facing device manufacturers is enabling clinicians to use tech solutions and educating them on when to integrate tech into their workflow. This project aims to provide device manufacturers with a best practices framework to give clinicians necessary device selection information, such as standards-based metrics for accuracy, privacy and security.

This effort, which will look at three use cases of devices – prevention, screening or diagnosis, and health management or treatment – is co-chaired by Mike McConnell, M.D., MSEE, senior clinical lead, Google Health and clinical professor, Stanford School of Medicine: and Ritu Thamman, M.D., FACC, ACC Innovation Work Group member. In addition, the working group members include representatives from Abbott, BioIntellisense, HP, Omron Healthcare Inc., Philips, Samsung Electronics, Valencell and Well Being Digital Limited (WBD101).

“The digital healthcare market is growing rapidly, and clinicians need to be confident in the appropriateness of devices for different patient groups,” Thamman said. “By providing best practices for new apps and devices, clinicians and patients can be assured that they are using the most appropriate digital tools to enhance care options and potentially improve patient outcomes.”

This work also builds upon a unique digital health whitepaper released last year by CTA and the Heart Rhythm Society that recommended best practices for using wearable technology to manage personal health, including detecting and monitoring cardiovascular biometrics.

The working group will hold a series of meetings in 2021 and is scheduled to release the best practices document by the end of the year.

Watch the related VIDEO: ACC Efforts to Advance Evidence-based Implementation of AI in Cardiovascular Care — an interview with John Rumsfeld, M.D.

About Consumer Technology Association (CTA)

As North America’s largest technology trade association, CTA is the tech sector. Our members are the world’s leading innovators – from startups to global brands – helping support more than 18 million American jobs. CTA owns and produces CES – the most influential tech event in the world. Find us at CTA.tech

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.

Wearable Cardiac Devices Market Will See Rapid Expansion in Coming Years

Find more content on wearable cardiac devices

Related Content

Feature | ACC | By Melinda Taschetta-Millane

In April, the cardiology community converged face-to-face in Orlando for The American College of Cardiology’s (ACC22) ...

Home May 11, 2022
Home
News | ACC

April 12, 2022 – The American College of Cardiology (ACC) is establishing a new award in honor of Valentin Fuster, MD ...

Home April 12, 2022
Home
News | ACC
April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...
Home April 04, 2022
Home
News | ACC

April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...

Home April 03, 2022
Home
News | ACC

April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...

Home April 03, 2022
Home
News | ACC

April 1, 2022 — Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
News | ACC
March 31, 2022 – Healthcare AI solutions provider Aidoc will be delivering a live demonstration of its comprehensive AI ...
Home March 31, 2022
Home
News | ACC
March 31, 2022 – Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and ...
Home March 31, 2022
Home
News | ACC
March 31, 2022 – CathWorks has announced that the results of its most recent outcomes study on the CathWorks FFRangio ...
Home March 31, 2022
Home
News | ACC
February 15, 2022 — The American College of Cardiology’s Cardiovascular Summit Virtual (CV Summit) will feature three ...
Home February 15, 2022
Home
Subscribe Now